Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by DavidRosenbergon Nov 02, 2021 6:20pm
53 Views
Post# 34079641

RE:RE:RE:Shareholders “letters” interesting

RE:RE:RE:Shareholders “letters” interesting
JAKPUG4LIFE wrote: New investors beware of David Rosenberg, Paid promoter for Anthony Durkacz. Social Media "Butterfly" he calls himself, 24hrs a day on all platforms including his 6 facebook groups, all AD related companies. Never speaks of financials or past history just posts promo videos and releases repetitively. Hopes and dreams, time will tell. Claims he has his life savings in this, yeah right, life savings of my shares thru a backdoor administrative payment maybe. If you have life savings in this and have no issues with was has happened over the last 3yrs we know you are full of shite. And by the way, AD is all part if all lawsuits FSD has ever had. Founder, board member and now intern ceo since the beginning. Watch out for Rosenberg, do your DD. Not to be trusted.
DavidRosenberg wrote:
GrahamB wrote: Read the comments at the bottom of the webpage regarding the successful lawsuit against FSD
Know that the past experiences with management can be helpful in judging the future success of the company 


https://thedeepdive.ca/fsd-pharma-ends-class-action-lawsuit-with-5-5-million-settlement/



Great so should we sell all our shares because of that? 

Should we not care about psychedelic space anymore or the new things they are working on , should we keep spamming about the lawsuit settlement from the past with Raza Bokhari as CEO at the time?
 What do you advise we should do graham sell all of our shares?





Im not a paid promoter I am a FSD Pharma Shareholder.  STop with the lies and fear mongering

Mr Shortseller

FYI 




"Short and distort" is a type of securities fraud in which investors short sell a stock and then spread negative rumors about the company in an attempt to drive down stock prices.[1][2][3]

It is often performed as a form of naked short selling in which stock is sold without being borrowed and without any intent to borrow.[4][5] Once the stock price has declined, the investor uses the proceeds of the initial sale to buy a larger number of the company's shares than sold originally. Some of the newly purchased stock is used to fulfill the short-selling contract; the remaining shares are then offered for sale, which causes an additional decline in the company's share price.

During the takeover of The Bear Stearns Companies by J.P. Morgan Chase in March 2008, reports swirled that short sellers were spreading rumors to drive down Bear Stearns' share price.[6] Democratic Senator Christopher Dodd felt this was more than rumors and said, "This is about collusion."[7] Chase was victimized by a similar "short and distort" scheme six years earlier when rumors arose about its purported relationship with Enron.[8]

In a December 2006 interview from TheStreet.com's "Wall Street Confidential" webcast, Jim Cramer stated that some hedge fund managers spread false rumors about companies to the media and trading desks to drive a stock down: " ...it's important to create a new truth, to develop a fiction."[9] Cramer said this practice, although illegal, is easy to do "because the SEC doesn't understand it."[10]

Cramer said one strategy to keep a stock price down is to spread negative rumors to reporters he described as "the Pisanis of the world" in reference to CNBC's Bob Pisani. "You have to use these guys," said Cramer. He also discussed getting "the bozo reporter from The Wall Street Journal" to publish a negative article.[11]

 

<< Previous
Bullboard Posts
Next >>